Related Experiment Video
Updated: Feb 7, 2026

Saturated Fatty Acids Induce Ceramide-associated Macrophage Cell Death
Published on: October 31, 2017
The anticancer peptide RT53 induces immunogenic cell death
Ewa Pasquereau-Kotula1, Justine Habault1,2, Guido Kroemer3,4,5,6,7,8,9
1INSERM UMRS1160, Institut Universitaire d'Hématologie, Hôpital Saint-Louis, Paris, France.
RT53 peptide induces immunogenic cell death (ICD) in cancer cells, triggering an immune response. This peptide shows potential as a novel anticancer immunotherapy, preventing tumor growth and causing regression in established cancers.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Immunogenic cell death (ICD) is a promising anticancer therapy strategy.
- Few chemotherapeutics currently induce ICD.
- The peptide RT53 selectively kills cancer cells and shows potential in vaccination models.
Purpose of the Study:
- To investigate if the peptide RT53 induces immunogenic cell death (ICD) in cancer cells.
- To evaluate RT53's potential as an anticancer immunotherapeutic agent.
Main Methods:
- Assessed hallmarks of ICD: calreticulin exposure, ATP release, and HMGB1 release.
- Evaluated RT53 in prophylactic mouse models using RT53-treated fibrosarcomas for vaccination.
- Administered RT53 intratumorally in established cancers to assess tumor regression and immune response.
Main Results:
- RT53 treatment induced key ICD markers: surface calreticulin, ATP release, and HMGB1 exodus.
- Vaccination with RT53-treated fibrosarcomas prevented tumor growth in a prophylactic model.
- Intratumoral RT53 injection caused tumor regression, T-cell infiltration, and inflammation.
Conclusions:
- RT53 induces bona fide immunogenic cell death in cancer cells.
- RT53 demonstrates significant potential as a novel antitumor and immunotherapeutic strategy.
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Peptide Bonds
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
Peptide Identification Using Tandem Mass Spectrometry
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...

